当前位置：药药网 / 数据中心 /变体注释摘要_药物剂量、反应、代谢
艾塞那肽-exenatide
记事
Each G allele decreased the 48-week reduction of HbA1c by 0.34%. This result meant that patients with the homozygous mutant genotype (GG, 21%) had 鈭?.68% (6.97 mmol/l) lower HbA1c reduction than those with the wild-type genotype (TT, 28%).
专家论述
Allele G is associated with decreased clinical benefit to exenatide in people with Diabetes Mellitus, Type 2 as compared to allele T.